𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The disposition and metabolism of (+)-cyanidanol-3 in patients with alcoholic cirrhosis

✍ Scribed by M. V. Smillie; L. A. Griffiths; P. J. Male; M. M. Wermeille

Publisher
Springer
Year
1987
Tongue
English
Weight
413 KB
Volume
33
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of epinephrine on glucose metabo
Effects of epinephrine on glucose metabolism in patients with alcoholic cirrhosis
✍ T Schricker; G Albuszies; H Weidenbach; K Beckh; H Ensinger; T AnhΓ€upl; P Raderm πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 201 KB πŸ‘ 2 views

ture of 21 to 24ЊC, and were kept as little disturbed as possible during sity, Ulm, Germany. the entire investigation. Monitoring was performed using automatic

Pneumococcal Vaccination: The Response o
Pneumococcal Vaccination: The Response of Patients with Alcoholic Liver Cirrhosis
✍ Mauro Pirovino; Eva Lydick; Peter J. Grob; Stephan Arrenbrecht; Josef Altorfer; πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 349 KB

Patients with cirrhosis have an increased risk of dying from pneumococcal pneumonia. Their immunological response to pneumococcal vaccination is not known. We compared the antibody response to challenge with a 14-valent purified pneumococcal polysaccharide vaccine in 15 patients with biopsy-proven a

Disposition and Metabolism of Metronidaz
Disposition and Metabolism of Metronidazole in Patients with Liver Failure
✍ Geoffrey Farrell; Judith Baird-Lambert; Mara Cvejic; Neil Buchanan πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 539 KB

A pharmacokinetic study of metronidazole disposition was performed in 10 patients with severe liver disease, the majority of whom also had impaired renal function. Following a single intravenous dose, systemic clearance of metronidazole was decreased by 66% in patients compared with healthy

Differences in the metabolism and dispos
Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis
✍ Pietro Invernizzi; Kenneth D. Setchell; Andrea Crosignani; Pier Maria Battezzati πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 180 KB πŸ‘ 2 views

The clinical effectiveness of ursodeoxycholate in the treatment of liver disease may be limited by its poor absorption and extensive biotransformation. Because in vitro and in vivo studies suggest that the more hydrophilic bile acid tauroursodeoxycholate has greater beneficial effects than ursodeoxy